05.08.2024

Medicine sales went up by 15.5% in the first quarter of 2024 from the year-earlier period, to RON8.15 billion, as retail sales rose by 14.4% and hospital consumption increased by 22.5%, in line with a more

02.01.2024

Romanians bought medicines worth RON26.8 billion (EUR5.44 billion) in the period April 2022 – March 2023, at wholesale prices, 20% more than in the year-earlier period, in line with a report of more

11.13.2023

The value of medicines prescribed to patients in Romania in the October 2022-September 2023 period reached RON28.7 billion (EUR5.8 billion) at wholesale prices, up 16% from the year-earlier period, in more

05.05.2023

Romanians bought medicines worth RON26.8 billion (EUR5.44 billion) in the period April 2022 – March 2023, at wholesale prices, 20% more than in the year-earlier period, in line with the Cegedim more

03.17.2023

Nuclear power producer Nuclearelectrica (SNN.RO) advances the development of nuclear medicine in Europe through an innovative agreement with BWXT Medical Ltd., part of BWX Technologies, Inc. more

11.17.2022

Romanians bought medicines worth RON24 billion (EUR5 billion) in the period October 2021 – September 2022, at wholesale prices, 21% more than in the year-earlier period, in line with the Cegedim more

07.05.2022

The Carol Davila University of Medicine and Pharmacy in Bucharest has bought an office building on Thomas Masaryk Street, owned by MAD Planning & Projects, where it will set up a medical simulation more

02.03.2022

The pharmaceutical market in Romania generated sales of over RON21 billion in 2021, up 17% from the previous year, according to data provided by market research company Cegedim. more

10.26.2020

Swiss drugmaker Novartis, which owns in Romania the Sandoz medicine factory in Targu-Mures, is building a drug testing center and a new manufacturing line that will increase the packaging capacity by more

02.04.2019

Sales of over the counter cold and flu drugs rose by 20% in pharmacies in January, after the authorities announced a national flu epidemic. more

05.17.2018

more

11.02.2017

Thousands of generic medicines will vanish from the Romanian market as the clawback increased 25% in the third quarter and will drive the local pharmaceutical industry out of business, the Romanian more

09.13.2017

more

11.18.2015

Shareholders of drugmaker Sintofarm (SINT.RO) will meet on December 21 to decide on the sale of equipment, brands and other assets except for buildings, and on renaming the company Imosint and turning more

11.17.2015

Medicine sales in Romania fell 9.9% on the year to RON2.74 billion in the third quarter, considering distribution prices, following the price cut of prescription drugs, according to Cegedim's Pharma & more

08.24.2015

Medicine sales in Romania fell 4.1% on the year to RON2.83 billion in the second quarter, considering distribution prices, according to Cegedim's Pharma & Hospital Report. more

12.05.2014

Anima, a company that entered the private healthcare market in 2010, envisages “solid” investments to develop its network of family medicine clinics, both through acquisitions and greenfield more

02.06.2014

Drugmakers operating in Romania will have to cease investments in 2014 and give up unprofitable products due to the 30% increase of the clawback tax in the fourth quarter of 2013, Dragos Damian, more

11.18.2013

The exports of Sanofi Romania’s Zentiva plant in Bucharest have reached 14% of its production, from 8% last year, says Christophe Gourlet, the general manager of the company. more

10.22.2013

Parallel exports of medicines fell this year compared with 2012 and 30%-40% of parallel trade is made through retail drugstores engaged in wholesale distribution, according to the Association of more

08.20.2013

Romanian pharmaceutical wholesalers Mediplus, Polisano and Farmexim and drug producers Europharm, Sandoz and Infomed Fluids were among the ten largest local medicine exporters last year, according to more

07.10.2013

Slovenian pharmaceutical group Krka expects its sales in Romania will increase in 2013, as the company will launch over 10 new products by the end of the year. more

06.05.2013

Cold medicine Fervex has been withdrawn from drugstores after U.S. pharmaceutical company Bristol-Myers Squibb found a contaminated lot in its Upsa factory in France, Romania’s National Medicines more

05.08.2013

Anglo-Swedish medicine producer AstraZeneca posted $161 million sales in Romania last year, up 4.5% from $154 million in 2011. more

04.09.2013

The priority of the new owner of pharmaceutical producer Labormed, Alvogen, is to make the company less reliant on the Romanian market, says Laurentiu Scheusan, Alvogen’s executive vice president of more